Deny Organ Transplants to Marijuana Users?
It has been said that people who use marijuana shouldn ' t receive transplants because they may have liver damage or they may not comply with medical regimens. Is it time to revisit that guideline? (Source: Medscape General Surgery Podcast)
Source: Medscape General Surgery Podcast - September 23, 2013 Category: Surgery Authors: Medscape Source Type: podcasts
Coagulation in Liver Disease: A Guide for the Clinician
An article in the September issue of CGH summarizes the pathophysiology of hemostasis in liver disease, describes pros and cons of lab tests for those patients, and outlines the optimal management of hemostasis for various clinical scenarios. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 7, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts
Bed blues
In this week ’s podcast, Margaret McCartney examines Hydration for Health, Quentin Anstee explains how big a problem non-alcoholic fatty liver disease is, and Patrick Keown explains the association between provision of mental health beds and the involuntary admission of mental health patients. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Bed blues
In this week’s podcast, Margaret McCartney examines Hydration for Health, Quentin Anstee explains how big a problem non-alcoholic fatty liver disease is, and Patrick Keown explains the association between provision of mental health beds and the involuntary admission of mental health patients. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 28, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Sudden death in epilepsy; NAFLD mortality
Mariana Lazo, from Johns Hopkins Bloomberg School of Public Health, tells us how non-alcoholic fatty liver disease has affected all cause mortality in the US. Also, Ley Sander, from University College London, discusses the problem of sudden death in epilepsy. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Nonalcoholic Fatty Liver Patients
A study in the July issue of CGH compares the colonic microbiome and volatile organic compound metabolome of obese nonalcoholic fatty liver disease patients with that of healthy-weight individuals. Dr. Kuemmerle speaks to author Dr. Kevin P. Rioux. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 5, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts
Fatty Liver Takes Center Stage
The number of abstracts and posters on fatty liver at DDW 2013 demonstrates the significance of this increasingly prevalent liver disorder. (Source: Medscape Pediatrics Podcast)
Source: Medscape Pediatrics Podcast - June 4, 2013 Category: Pediatrics Authors: Medscape Source Type: podcasts
Fatty Liver Takes Center Stage
The number of abstracts and posters on fatty liver at DDW 2013 demonstrates the significance of this increasingly prevalent liver disorder. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - June 4, 2013 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 3, 2013 Category: Pharmaceuticals Source Type: podcasts
Dr. Vincent Khoo on Oligometastatic prostate cancer
Prostate cancer is not a single disease. Oligometastatic disease is an emerging concept in prostate cancer, though it has been seen in other cancers such as, breast and liver. Dr. Vincent Khoo of the ...
Author: vhsimons
Added: 02/22/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2013 Category: Cancer & Oncology Source Type: podcasts
Tolvaptan and Liver Damage Warnings: Tip of the Iceberg?
Jeffrey Berns talks about the FDA warnings concerning liver damage with the use of tolvaptan, recently approved for polycystic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 21, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
